<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2899">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04416919</url>
  </required_header>
  <id_info>
    <org_study_id>11887</org_study_id>
    <nct_id>NCT04416919</nct_id>
  </id_info>
  <brief_title>Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment</brief_title>
  <official_title>A Proposed Alternative to the N-95 Mask Shortage in the COVID-19 Pandemic. A Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>US Department of Veterans Affairs</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oklahoma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the safety and efficiency of an assembled modified
      mask in protecting health care workers against Coronavirus in case of any personal protective
      equipment shortage. At least 20 healthy participants will be recruited to try the modified
      mask. The modified masks will be made from masks that are already available as well as
      filters available in the pulmonary department at the Oklahoma City VA Health Care System
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 15, 2020</start_date>
  <completion_date type="Anticipated">May 2025</completion_date>
  <primary_completion_date type="Anticipated">May 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success Percentage</measure>
    <time_frame>15 minutes</time_frame>
    <description>Conduct a quantitative fit test and calculate the percentage of participants who pass the test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>End-tidal CO2 Variation. Description: mmHg.</measure>
    <time_frame>at 0 and 15 minutes</time_frame>
    <description>Change in end-tidal CO2 from 0 to 15 minutes while wearing the Full or the Whole mask</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen Pulse Oximetry Variation. Description: mmHg.</measure>
    <time_frame>at 0 and 15 minutes.</time_frame>
    <description>Measure the change in Oxygen Pulse Oximetry from 0 to15 minutes while wearing the Full or the Whole mask</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mask Visibility. Description: Likert Scale.</measure>
    <time_frame>15 minutes</time_frame>
    <description>Evaluate the visibility (5-point Likert scale from Absent to Complete) while wearing the Full or the Whole mask for 15 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Willingness of usage. Description: Likert Scale.</measure>
    <time_frame>after 15 minutes</time_frame>
    <description>When the mask is removed, participants will be asked about willingness to use this mask compared to N-95 masks using a 5-point Likert scale from 'Very unlikely' to 'Very likely'.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Coronavirus Infection</condition>
  <condition>Disease Prevention</condition>
  <arm_group>
    <arm_group_label>Assembled Mask</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participant will be fitted with a full-face mask that covers the mouth and nose or a Whole face mask that covers the eyes, nose, and mouth depending on participant's preferences. The Fitted Mask will be attached to a bacterial/viral filter for fit testing. After completing the Fit test, the mask will be placed on the face for 15 minutes while the participant performs various activities to document the ability to tolerate the respirator. Participants oxygen and carbon dioxide level will be measured in the beginning and at the end of the 15 minutes. The individuals will be able to remove the Mask anytime if they experience significant discomfort or claustrophobia. At the end, the mask will be removed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Assembled mask</intervention_name>
    <description>Assembled masks consisting of 3 parts: A facemask (Respironics Performax Whole Face Mask or Hans Rudolph mask naso-oral mask) linked by a blue elbow ( RP Performax SE ELBOW) to a ventilator filter (Teleflex Bacterial/Viral filter 1605 or Iso-Gard HEPA light Filter 28022)</description>
    <arm_group_label>Assembled Mask</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. All individuals older than 18 years of age, and willing to participate in the study

        Exclusion Criteria:

          1. Individuals with known severe COPD/emphysema, Obesity Hypoventilation or hypercapnic
             condition

          2. Individuals with allergy or reactions to latex or masks

          3. Individuals reporting dyspnea or unable to breathe comfortably in these masks

          4. Claustrophobic individuals

          5. Inability to create a proper Seal while inhaling through a closed filter (See Below)

          6. Individuals who cannot safely apply and remove these masks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Houssein Youness, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oklahoma HSC - OKC Veterans Affairs Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Houssein Youness, MD</last_name>
    <phone>405-271-6173</phone>
    <email>Houssein-Youness@ouhsc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahel El Haj Chehade, MD</last_name>
    <phone>405-271-6173</phone>
    <email>Ahel-ElHajChehade@ouhsc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oklahoma City VA Health Care System</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Houssein Youness, MD</last_name>
      <phone>405-271-6173</phone>
      <email>Houssein-Youness@ouhsc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Prevention CfDCa. Strategies for Optimizing the Supply of Facemasks: COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/face-masks.html</citation>
  </reference>
  <results_reference>
    <citation>van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.</citation>
    <PMID>32182409</PMID>
  </results_reference>
  <results_reference>
    <citation>Qian Y, Willeke K, Grinshpun SA, Donnelly J, Coffey CC. Performance of N95 respirators: filtration efficiency for airborne microbial and inert particles. Am Ind Hyg Assoc J. 1998 Feb;59(2):128-32.</citation>
    <PMID>9487666</PMID>
  </results_reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 13, 2020</study_first_submitted>
  <study_first_submitted_qc>June 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2020</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>2019 novel coronavirus disease</keyword>
  <keyword>2019 novel coronavirus infection</keyword>
  <keyword>COVID-19 pandemic</keyword>
  <keyword>COVID-19 virus disease</keyword>
  <keyword>COVID19</keyword>
  <keyword>COVID-19 virus infection</keyword>
  <keyword>N-95</keyword>
  <keyword>Respiratory protective devices</keyword>
  <keyword>Protection from respiratory infecton</keyword>
  <keyword>Safety</keyword>
  <keyword>Efficacy</keyword>
  <keyword>Pandemic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

